Inhalt
Begrüssung.- Prof. Dr. Ludwig E. Feinendegen.- Prof. Dr. Heinz Schröer.- Prof. Dr. Harald Feldmann.- Direktor Otto Heller.- 1 Primary Prevention of Cardiovascular Disease. Recent Trials.- 2 Secondary Trials after Myocardial Infarction: A Review.- 3 Münster Studies of Coronary Heart Disease.- 4 Prediction and Early Detection of Coronary Heart Disease.- 5 Progression of Coronary Artery Disease as Judged from Sequential Angiography.- 6 New Non-Invasive Ways to Measure Plaque Size, their Development and Implications.- 7 Endothelial Injury and Repair.- 8 Extracellular Matrix Proteins of the Vessel Wall: Are they Possible Markers of Atherosclerotic Processes?.- 9 External Measuring of Myocardial Structure and Function.- 10 Immunological Anomalies in High Risk Women on the Pill.- 11 Diet in Experimental Atherosclerosis.- 12 Cardiovascular Effects of Exercise in Primate Atherosclerosis.- 13 Prostacyclin and Atherosclerosis Experimental and Clinical Approach.- 14 Antirheumatic Drugs and their Influence on Arterial Wall Cells of Normal and Injured Animals.- 15 Effects of Alfalfa Saponins on Regression of Atherosclerosis in Monkeys.- 16 The Effect of Alcohol on Human Platelet Function. The Role of Platelet Membrane and Plasma Lipids.- 17 Effect of the Anthocyanosides of Vaccinium myrtillus on the Vascular Wall.- 18 Growth Factors and Atherogenesis.- 19 Significance of Coagulation in Atherogenesis.- 20 Contribution of Blood Platelets to the Pathogenesis of Myocardial Infarction.- 21 Isovolemic Hemodilution as a Functional Therapy of Decompensated Arteriosclerotic Stenoses of the Femoral, Cerebral and Ophthalmic Artery.- 24 The Role of HDL Cholesterol in Preventive Medicine.- 25 LDL and HDL in Human Arteries Role in Atherogenesis.- 26 A New Tracer for the Metabolic Fateof Cholesteryl Ester.- 27 The Latest Evidence, in vitro and in vivo, on Controlling Smooth Muscle Cell Proliferation and Arterial Wall Cholesterol Ester Accumulation by Controlling LDL Concentration.- 28 Summary Chapter.- 29 Final Remarks.